A new “auditable hemocompatibility dashboard” was reported to turn guidance for HeartMate 3 management into a more reliable outpatient care workflow. The tool focuses on clots and bleeding risk—key adverse events in mechanical pump recipients—by providing structured visibility into patient-specific parameters that influence hemocompatibility decisions. For transplant and advanced heart failure programs, the update aims to reduce variability in how clinicians interpret guidance outside the hospital setting, supporting safer transitions to long-term care.